SAFE OBSTETRIC SYSTEMS LIMITEDActive

Company number 05923369Private limited companyIncorporated 2006

Key figures

£2,716,227+2.9%
Net assets 2021/22
+16.0%
Average annual growth 2020–2021/22
01 m2 m3 m20202020/212021/22

Ratios

2021/22
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m20202020/212021/22

Dividends

from the accounts
2020/21

Dividends paid in the financial year: £35,997,965 (98% of the profit for the year).

Filed accounts2020–2021/22
20202020/212021/22
Turnover—1,775,2761,969,912
Profit for the year—36,618,41576,320
Cash at bank and in hand1,613,59727,453227,793
Total assets2,313,7352,748,5103,162,043
Total liabilities293,773108,603446,312
Net assets / total equity2,019,4572,639,9072,716,227
Average number of employees621
Average pay (per year)—188,768204,166
Dividends paid—-35,997,965—

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SAFE OBSTETRIC SYSTEMS LIMITED

Company

SAFE OBSTETRIC SYSTEMS LIMITED is a private limited company registered with Companies House under company number 05923369. It was incorporated on 4 Sep 2006. Its status is active. The registered office is in Fareham (PO15). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500).

Accounts

The latest accounts in the database are for 2021/22 (period ending 31 Oct 2022); the company files full accounts. Turnover was £1,969,912. Profit for the year was £76,320. Net assets were £2,716,227, up 2.9% on the previous year. Cash at bank and in hand was £227,793. Total assets were £3,162,043 and total liabilities £446,312. The company had an average of 1 employee. Figures are available for 3 financial years (2020–2021/22).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 18 Sep 2027.